Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3870581 | 0.84 | DAO (0.33) | — | |
| SCHEMBL19285687 | 0.75 | — | — | |
| SCHEMBL3881256 | 0.73 | — | — | |
| SCHEMBL9219918 | 0.70 | — | — | |
| SCHEMBL3873607 | 0.69 | GSK3A (0.31) | — | |
| SCHEMBL7533382 | 0.69 | — | — | |
| SCHEMBL8973472 | 0.68 | TAAR1 (0.34) | SLC6A2TAAR1SLC6A3MAOASLC6A4 | |
| SCHEMBL5941211 | 0.65 | GSK3A (0.31) | — | |
| SCHEMBL2133958 | 0.65 | GSK3A (0.31) | — | |
| SCHEMBL12030900 | 0.64 | GSK3A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426310-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | Mynd Life Sciences Inc. (CA) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023077234-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC. (CA) | 2023-05-11 | — | — | WO | disclosed |